Clinical Trial Update: Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

The update reports safety data and exploratory efficacy signals from a Phase 2 trial of Kanglaite Injection in Stage IV non-small cell lung cancer, which has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Kanglaite Injection (Kanglaite)

Snippet

Sponsor: KangLaiTe USA | Conditions: Stage IV NSCLC | Phase 2 | Status: TERMINATED